Page last updated: 2024-10-22

amifostine anhydrous and Osteitis Deformans

amifostine anhydrous has been researched along with Osteitis Deformans in 1 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Osteitis Deformans: A disease marked by repeated episodes of increased bone resorption followed by excessive attempts at repair, resulting in weakened, deformed bones of increased mass. The resultant architecture of the bone assumes a mosaic pattern in which the fibers take on a haphazard pattern instead of the normal parallel symmetry.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pahlavan, PS1

Other Studies

1 other study available for amifostine anhydrous and Osteitis Deformans

ArticleYear
Pagets disease of the bone.
    Saudi medical journal, 2000, Volume: 21, Issue:4

    Topics: Amifostine; Anti-Inflammatory Agents; Calcitonin; Calcium; Diphosphonates; Disease Progression; Drug

2000